The FT Pharmaceutical & Biotechnology Conference attracts senior level executives and corporate decision-makers from around the world including Chairmen, CEOs, CFOs, Presidents and Managing Directors from:
- Pharmaceutical and biotechnology companies
- Medical devices, medical technology, instrumentation and diagnostics companies
- Health insurers, government and private health service providers
- Regulatory agencies and health technology assessment bodies
- Investment banks,private equity,venture capital, pension and IP funds
- Patient representative organisations, health NGOs and social media consultancies
A SELECTION OF OUR 2013 ATTENDEES INCLUDED:
- Accenture
- Amgen
- AstraZeneca
- European Association of Pharmaceutical Industries and Associations
- Fleishman Hillard
- Genpact
- Integrated Medicines Ltd
- Microgen
- MMR-G
- Novaquest
- Novartis
- Oracle
- Pfizer
- Pharmaceutical Strategies Group, LLC
- PwC
- Russell Reynolds Associates
- Teva Pharmaceutical Industries
